AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Lumizyme market seen expanding on rare disease demand
AGP
The Business Research Company says the global Lumizyme market should keep growing through 2035, driven by more rare disease diagnoses, rising healthcare spending and wider use of home infusion care.
Luxturna market seen growing on gene therapy demand and rare eye disease focus
AGP
The Business Research Company says the Luxturna market is set to expand through 2035 as gene therapy adoption rises, rare retinal disorder diagnosis increases and healthcare spending climbs.
Libmeldy market study points to faster growth in rare disease gene therapy
AGP
The Business Research Company says the global Libmeldy market is poised to expand through 2035 as gene therapy, newborn screening and rare disease diagnosis improve.
Evkeeza market set for growth on genetic screening and rare disease demand
AGP
The Business Research Company says the Evkeeza market is positioned for steady expansion through 2035 as genetic screening, biologic adoption and reimbursement for rare diseases improve access to treatment.
Human albumin market set for steady growth as chronic disease demand rises
AGP
The global human albumin market is expanding as more patients need plasma-based therapy for surgery, burns, trauma and chronic disease management.
Flexbumin market set for growth as surgery, liver disease and burns rise
AGP
The Business Research Company says the global Flexbumin market is expanding on rising surgical procedures, liver disease and burn injuries, with North America leading in 2025 and Asia-Pacific expected to grow fastest.
Batten disease research conference comes to Boston for the first time
AGP
Boston will host the NCL Translational Science and Therapeutics Conference for the first time Nov. 11-13, bringing international researchers, clinicians, industry groups and advocates together to advance Batten disease research.
Sage Healthcare adds directors in the US and Europe
AGP
Sage Healthcare has appointed Joe Smith in the United States and Dr Rino Coladangelo in the United Kingdom as directors, expanding its transatlantic dealmaking bench.
Xiantao S&J expands protective product lineup for global buyers
AGP
Xiantao S&J Protective Products Co., Ltd. is broadening its disposable protective product offer for healthcare, dental, laboratory and industrial customers.
Nurses Lounge launches Nurse FLEX Pool for local nurse staffing
AGP
Nurses Lounge has launched Nurse FLEX Pool, an AI-powered mobile platform that lets healthcare facilities build and manage local nurse pools through a subscription-fee model.
KSMModel.ai says healthcare AI visibility score rose 50 points in 30 days
AGP
KSMModel.ai released Day 30 results from its 90-day study with Bayside, Queens practice PeptideDoc, saying the organization’s AI visibility score climbed to 85 out of 100 from a 35-point baseline.
AORN offers 3 ways perioperative nurses can use AI
AGP
AORN has released new guidance on how perioperative nurses can integrate artificial intelligence into clinical practice without losing sight of patient safety and clinical judgment.
Tells.co to discuss healthcare SMS at HLTH USA 2026
AGP
Tells.co will attend HLTH USA 2026 in Las Vegas from Nov. 15-18 to talk with healthcare teams about permission-based SMS for reminders, follow-up and human handoff.
Clesson Healthcare Law opens private practice and launches new website
AGP
Clesson Healthcare Law, P.C. has opened a private practice and launched clessonlaw.com, targeting healthcare professionals and small healthcare businesses in California, Illinois and Tennessee.
AI rare disease patient finder market seen nearly tripling by 2030
AGP
The market for AI-powered rare disease patient finders is projected to jump from $1.62 billion in 2025 to $5.95 billion by 2030 as drugmakers and researchers push harder for faster trial recruitment and better patient matching.
Enbrel Mini market seen growing on self-injection demand and autoimmune disease rise
AGP
The Business Research Company says the Enbrel Mini market is positioned for long-term growth as more patients seek self-administered biologics and easier injection devices.
AI-powered rare disease diagnosis market seen reaching $7.08B by 2030
AGP
The Business Research Company says the AI-powered rare disease diagnosis market is set to surge from $2.56 billion in 2026 to $7.08 billion by 2030, driven by genetic testing, personalized medicine and faster clinical decision-making.
Euvichol market seen growing as liver disease cases rise
AGP
The Business Research Company says demand for Euvichol and Euvichol-Plus is being lifted by rising liver disease rates, broader screening and higher healthcare spending.
Nobis names 2026 hospital division award winners
AGP
Nobis recognized top-performing hospitals at its annual Hospital Division Meeting, held Oct. 13-15, 2026, and highlighted achievements in patient experience, teamwork, community service and financial performance.
AI hospital energy market seen topping $7.15 billion by 2030
AGP
The Business Research Company says AI-driven hospital energy optimization will grow from $2.49 billion in 2025 to $3.08 billion in 2026, then to $7.15 billion by 2030. The report points to smart hospital infrastructure, remote monitoring and…
Sign up for:
Today in Healthcare
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.